China’s medical treatment establishments, including hospitals, clinics and nursing homes, are now fully open to foreign investment. With an aging population and a growing middle class that is increasingly able to afford premium private healthcare services, it is not surprising that China is one of the most attractive destinations for foreign health care companies.
MWE China Law Offices’ Health Care Practice Group provides clients with a full range of support and services at every stage of the health care continuum. Our lawyers, patent agents and scientific advisors understand the specific needs of hospitals, clinics and other health care providers, and are well versed in the many areas of law that can affect their business, financial and clinical operations. We have counseled some of the world’s largest health care companies, academic medical research centers, universities, investment banks, venture capital firms and start-ups on matters critical to their continued growth and success.
Our Health Care Group, whether working alone or as a globally integrated team with our counterparts at McDermott Will & Emery, regularly serves a broad range of clients within the health care, life sciences, pharmaceutical, and biotechnology and technology industries. We advise clients on intellectual property and licensing, general corporate matters, mergers and acquisitions (M&A) and joint ventures, compliance, product regulation and distribution, product liability, antitrust and competition, anti-corruption laws and the US Foreign Corrupt Practice Act (FCPA), tax, executive compensation, labor and employment, international trade and various regulatory compliance issues.